Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


01.10.2018

2 AJR Am J Roentgenol
1 Am J Pathol
1 BMC Cancer
1 BMC Gastroenterol
2 Dig Dis Sci
4 Eur Radiol
2 Hepatology
1 Int J Cancer
1 J Comput Assist Tomogr
2 J Hepatol
1 J Pediatr
3 Lancet
1 Lancet Gastroenterol Hepatol
1 Oncogene
1 Radiology
3 Transplant Proc
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. SHETTY AS, Mittal A, Salter A, Narra VR, et al
    Hepatopancreaticobiliary Imaging Second-Opinion Consultations: Is There Value in the Second Reading?
    AJR Am J Roentgenol. 2018 Sep 24:1-8. doi: 10.2214/AJR.17.19452.
    PubMed     Text format     Abstract available

  2. HORVAT N, Rocha MS, Chagas AL, Oliveira BC, et al
    Multimodality Screening of Hepatic Nodules in Patients With Congenital Heart Disease After Fontan Procedure: Role of Ultrasound, ARFI Elastography, CT, and MRI.
    AJR Am J Roentgenol. 2018 Sep 24:1-9. doi: 10.2214/AJR.18.19762.
    PubMed     Text format     Abstract available


    Am J Pathol

  3. STROWITZKI MJ, Kirchberg J, Tuffs C, Schiedeck M, et al
    Loss Of Prolyl-Hydroxylase 1 Protects Against Biliary Fibrosis Via Attenuated Activation Of Hepatic Stellate Cells.
    Am J Pathol. 2018 Sep 21. pii: S0002-9440(17)30621.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. AN C, Kim DY, Choi JY, Han KH, et al
    Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    BMC Cancer. 2018;18:915.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. FRIEDRICH D, Marschall HU, Lammert F
    Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    BMC Gastroenterol. 2018;18:76.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  6. YANNY B, Saab S, Durazo F, Latt N, et al
    Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naive Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5283.
    PubMed     Text format     Abstract available

  7. KORNBERG A, Schernhammer M, Kornberg J, Friess H, et al
    Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5296.
    PubMed     Text format     Abstract available


    Eur Radiol

  8. CALANDRI M, Yamashita S, Gazzera C, Fonio P, et al
    Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
    Eur Radiol. 2018;28:2727-2734.
    PubMed     Text format     Abstract available

  9. MARQUARDT S, Kirstein MM, Bruning R, Zeile M, et al
    Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5729.
    PubMed     Text format     Abstract available

  10. IYAMA A, Nakaura T, Iyama Y, Kidoh M, et al
    Spiral flow-generating tube for saline chaser improves aortic enhancement in Gd-EOB-DTPA-enhanced hepatic MRI.
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5733.
    PubMed     Text format     Abstract available

  11. JOO I, Lee JM, Lee DH, Jeon JH, et al
    Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5727.
    PubMed     Text format     Abstract available


    Hepatology

  12. SIRICA AE, Gores GJ, Groopman JD, Selaru FM, et al
    Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
    Hepatology. 2018 Sep 25. doi: 10.1002/hep.30289.
    PubMed     Text format     Abstract available

  13. WILKINSON PD, Delgado ER, Alencastro F, Leek MP, et al
    The polyploid state restricts hepatocyte proliferation and liver regeneration.
    Hepatology. 2018 Sep 23. doi: 10.1002/hep.30286.
    PubMed     Text format     Abstract available


    Int J Cancer

  14. LEE JH
    Analysis of The Cancer Genome Atlas data to determine the correlation between PROX1 and TERT in hepatocellular carcinoma.
    Int J Cancer. 2018 Sep 24. doi: 10.1002/ijc.31888.
    PubMed     Text format    


    J Comput Assist Tomogr

  15. STOCKER D, Bashir MR, Kannengiesser SAR, Reiner CS, et al
    Accuracy of Automated Liver Contouring, Fat Fraction, and R2* Measurement on Gradient Multiecho Magnetic Resonance Images.
    J Comput Assist Tomogr. 2018;42:697-706.
    PubMed     Text format     Abstract available


    J Hepatol

  16. DEUGNIER Y, Morcet J, Laine F, Hamdi-Roze H, et al
    Reduced phenotypic expression in genetic hemochromatosis with time: role of exposure to nongenetic modifiers.
    J Hepatol. 2018 Sep 20. pii: S0168-8278(18)32383.
    PubMed     Text format     Abstract available

  17. LOW JTS, Rohde G, Pittordou K, Candy B, et al
    Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals.
    J Hepatol. 2018 Sep 19. pii: S0168-8278(18)32381.
    PubMed     Text format     Abstract available


    J Pediatr

  18. IACOBAS I, Phung TL, Adams DM, Trenor CC 3rd, et al
    Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring.
    J Pediatr. 2018 Sep 21. pii: S0022-3476(18)31122.
    PubMed     Text format     Abstract available


    Lancet

  19. SCHACHTER J, Ribas A, Long GV, Arance A, et al
    Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
    Lancet. 2017 Aug 16. pii: S0140-6736(17)31601.
    PubMed     Text format     Abstract available

  20. CHARLTON M
    FGF-19 agonism for NASH: a short study of a long disease.
    Lancet. 2018;391:1124-1126.
    PubMed     Text format    

  21. REIG M, Bruix J
    Lenvatinib: can a non-inferiority trial change clinical practice?
    Lancet. 2018;391:1123-1124.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  22. ROWE IA
    Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease.
    Lancet Gastroenterol Hepatol. 2018;3:66-72.
    PubMed     Text format     Abstract available


    Oncogene

  23. DOU C, Zhou Z, Xu Q, Liu Z, et al
    Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway.
    Oncogene. 2018 Sep 24. pii: 10.1038/s41388-018-0505.
    PubMed     Text format     Abstract available


    Radiology

  24. CHERNYAK V, Fowler KJ, Kamaya A, Kielar AZ, et al
    Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
    Radiology. 2018 Sep 25:181494. doi: 10.1148/radiol.2018181494.
    PubMed     Text format     Abstract available


    Transplant Proc

  25. PAI SL, Aniskevich S 3rd, Logvinov II, Matcha GV, et al
    Hypertrophic Cardiomyopathy in Liver Transplantation Patients.
    Transplant Proc. 2018;50:1466-1469.
    PubMed     Text format     Abstract available

  26. COELHO GR, Praciano AM, Viana GNR, Lima CA, et al
    Outcomes of Liver Transplant Recipients With Model for End-Stage Liver Disease Exception: Single-Center Experience in the Northeast of Brazil.
    Transplant Proc. 2018;50:1428-1430.
    PubMed     Text format     Abstract available

  27. ERSHOFF BD, Gordin JS, Vorobiof G, Elashoff D, et al
    Improving the Prediction of Mortality in the High Model for End-Stage Liver Disease Score Liver Transplant Recipient: A Role for the Left Atrial Volume Index.
    Transplant Proc. 2018;50:1407-1412.
    PubMed     Text format     Abstract available


    Transplantation

  28. LU WY, Forbes SJ
    Telomerase Activity Links to Regenerative Capacity of Hepatocytes.
    Transplantation. 2018;102:1587-1588.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: